Bevacizumab/Doxorubicin/Radiation for Sarcoma
Clinical trial NCT01746238 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01746238
- Sponsor
- Massachusetts General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2016-05-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.